BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 1111472)

  • 1. IgD multiple myeloma. Review of 133 cases.
    Jancelewicz Z; Takatsuki K; Sugai S; Pruzanski W
    Arch Intern Med; 1975 Jan; 135(1):87-93. PubMed ID: 1111472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of abnormal immunoglobulin with clinical features of myeloma.
    Arch Intern Med; 1975 Jan; 135(1):46-52. PubMed ID: 1111470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
    Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
    Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal IgD. A comparative study of 60 sera with IgD "M" component.
    Fine JM; Rivat C; Lambin P; Ropartz C
    Biomedicine; 1974 Mar; 21(3):119-25. PubMed ID: 4429767
    [No Abstract]   [Full Text] [Related]  

  • 5. Monitoring myelomatosis.
    Hobbs JR
    Arch Intern Med; 1975 Jan; 135(1):125-30. PubMed ID: 1111461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [IgD-multiple myeloma. Review of 102 cases reported in the literature (author's transl)].
    Knolle J; Meyer KH
    Immun Infekt; 1975 Jul; 3(3):125-34. PubMed ID: 810409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical classification of plasma cell myeloma.
    Conklin R; Alexanian R
    Arch Intern Med; 1975 Jan; 135(1):139-43. PubMed ID: 1111462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodiagnosis of IgD multiple myeloma. A report of 17 cases.
    Chernokhvostova EV; Batalova TN; German GP; Andreyeva NE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):539-52. PubMed ID: 6170548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestations of multiple myeloma: relation to class and type M component.
    Pruzanski W
    Can Med Assoc J; 1976 May; 114(10):896-7. PubMed ID: 817790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple myeloma with double M-proteins of IgD-lambda and IgA-kappa].
    Maruyama Y; Tanikawa S; Sakamaki H; Yahara Y; Onozawa Y; Hayashi Y; Kawaguchi K; Koike M; Ozawa N; Shimizu M
    Rinsho Ketsueki; 1987 Aug; 28(8):1475-80. PubMed ID: 3430755
    [No Abstract]   [Full Text] [Related]  

  • 11. The frequency distribution of heavy chain classes and light chain types of 1,000 monoclonal immunoglobulins.
    Creyssel R; Gibaud A; Cordier JF; Boissel JP
    Biomedicine; 1975 Jan; 22(1):41-8. PubMed ID: 810190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgD myeloma L-type. Immunochemical study of the first Brazilian case.
    Ferri RG; Llach HF; Balthazar P; Cobra CJ; de Souza Júnior JA
    Rev Hosp Clin Fac Med Sao Paulo; 1971; 26(6):229-32. PubMed ID: 5006006
    [No Abstract]   [Full Text] [Related]  

  • 13. Kappa and lambda light chain disease: survival rates and clinical manifestations.
    Shustik C; Bergsagel DE; Pruzanski W
    Blood; 1976 Jul; 48(1):41-51. PubMed ID: 820387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgD plasma cell neoplasia: clinical manifestations and characteristic features.
    Pruzanski W; Rother I
    Can Med Assoc J; 1970 May; 102(10):1061-5. PubMed ID: 5000054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal disease in myeloma. Role of the tumor cell mass (author's transl)].
    San Miguel J; Batlle J; Alberca I; Moraleda JM; López Borrasca A
    Med Clin (Barc); 1981 Apr; 76(8):347-9. PubMed ID: 7253752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies in multiple myeloma. I. Characteristics by immunoglobulin class.
    Murphy WM; Deodhar SD
    Cleve Clin Q; 1973; 40(1):1-7. PubMed ID: 4693613
    [No Abstract]   [Full Text] [Related]  

  • 17. Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins.
    Isobe T; Osserman EF
    N Engl J Med; 1974 Feb; 290(9):473-7. PubMed ID: 4204196
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic factors in multiple myeloma: parametric analysis in each abnormal protein type.
    Oguma S; Takatsuki K; Uchino H
    Gan; 1981 Jun; 72(3):354-62. PubMed ID: 7319195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria.
    Sirohi B; Powles R; Kulkarni S; Rudin C; Saso R; Lal R; Singhal S; Mehta J; Horton C; Treleaven J
    Bone Marrow Transplant; 2001 Jul; 28(1):29-37. PubMed ID: 11498741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gel filtration analysis of multiple myeloma sera.
    Tóth I; Sellei C; Eckhardt S; Hindy I
    Haematologia (Budap); 1973; 7(1):7-16. PubMed ID: 4737470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.